Yoga, aerobic and stretching exercise effects on neurocognition: Randomized controlled trial protocol

被引:2
|
作者
Gothe, Neha P. [1 ,2 ,3 ,5 ]
Erlenbach, Emily [1 ]
Garcia, Veronica [1 ]
Malani, Revati [1 ]
Voss, Stephanie [1 ]
Camacho, Paul B. [2 ]
McAuley, Edward [1 ,2 ]
Burd, Nicholas [1 ]
Sutton, Bradley P. [2 ]
Damoiseaux, Jessica S. [4 ]
机构
[1] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA
[2] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA
[3] Northeastern Univ, Bouve Coll Hlth Sci, Boston, MA USA
[4] Wayne State Univ, Inst Gerontol, Dept Psychol, Detroit, MI USA
[5] Univ Illinois, Dept Kinesiol & Community Hlth, 906 S Goodwin Ave,Freer Hall 350, Urbana, IL 61801 USA
基金
美国国家卫生研究院;
关键词
Yoga; Mind -body therapies; Cognition; Executive function; Physical activity; ALTERNATIVE MEDICINE USE; FUNCTIONAL CONNECTIVITY; PHYSICAL-ACTIVITY; UNITED-STATES; OLDER-ADULTS; COGNITION; PERFORMANCE; SIZE;
D O I
10.1016/j.cct.2023.107240
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
As the global population ages, the prevalence of cognitive decline and dementia is expected to rise, creating a significant health and economic burden. The purpose of this trial is to rigorously test, for the first time, the efficacy of yoga training as a physical activity intervention to mitigate age-related cognitive decline and impairment. We are conducting a 6-month randomized controlled trial (RCT) of exercise among 168 middle aged and older adults to compare the efficacy of yoga vs. aerobic exercise on cognitive function, brain structure and function, cardiorespiratory fitness, and circulating inflammatory and molecular markers. Using a single-blind, three arm RCT, 168 older adults ages 55-79 will be assigned to either: a Hatha yoga group, an aerobic exercise group or a stretching-toning active control group. Participants will engage in hour long group exercise 3x/ week for 6-months. A comprehensive neurocognitive test battery, brain imaging, cardiovascular fitness test, and a blood draw will take place at baseline; end of the 6-month intervention, and at 12-month follow-up. Our primary outcomes of interest are brain regions, such as hippocampal volume and prefrontal cortex, and cognitive functions, such as episodic memory, working memory and executive functions, that are typically affected by aging and Alzheimer's disease. Not only will this RCT test whether yoga is a means to mitigate age-related cognitive decline, but it may also offer an alternative to aerobic exercise, which could be particularly appealing to older adults with compromised physical functioning. ClinicalTrials.gov Identifier: NCT04323163
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Yoga and aerobic exercise in epilepsy: Study protocol for a randomized controlled trial
    Aktar, Burcin
    Balci, Birgul
    Boz, Hatice Eraslan
    Oztura, Ibrahim
    Baklan, Baris
    PHYSIOTHERAPY RESEARCH INTERNATIONAL, 2023, 28 (04)
  • [2] Effects of yoga, aerobic, and stretching and toning exercises on cognition in adult cancer survivors: protocol of the STAY Fit pilot randomized controlled trial
    Gothe, Neha P.
    Erlenbach, Emily E.
    Streeter, Samuel L.
    Lehovec, Linda
    TRIALS, 2020, 21 (01)
  • [3] Effects of yoga, aerobic, and stretching and toning exercises on cognition in adult cancer survivors: protocol of the STAY Fit pilot randomized controlled trial
    Neha P. Gothe
    Emily D. Erlenbach
    Samuel L. Streeter
    Linda Lehovec
    Trials, 21
  • [4] Effects of yoga and aerobic exercise on wellbeing in physically inactive older adults: Randomized controlled trial (FitForAge)
    Welford, Paul
    Osth, Josefine
    Hoy, Sara
    Diwan, Vinod
    Hallgren, Mats
    COMPLEMENTARY THERAPIES IN MEDICINE, 2022, 66
  • [5] Effects of aerobic exercise on cognition and hippocampal volume in Alzheimer's disease: study protocol of a randomized controlled trial (The FIT-AD trial)
    Yu, Fang
    Bronas, Ulf G.
    Konety, Suma
    Nelson, Nathaniel W.
    Dysken, Maurice
    Jack, Clifford, Jr.
    Wyman, Jean F.
    Vock, David
    Smith, Glenn
    TRIALS, 2014, 15
  • [6] Effects of high-intensity aerobic exercise on psychotic symptoms and neurocognition in outpatients with schizophrenia: study protocol for a randomized controlled trial
    Engh, John A.
    Andersen, Eivind
    Holmen, Tom L.
    Martinsen, Egil W.
    Mordal, Jon
    Morken, Gunnar
    Egeland, Jens
    TRIALS, 2015, 16
  • [7] Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial
    Yu, Fang
    Vock, David M.
    Zhang, Lin
    Salisbury, Dereck
    Nelson, Nathaniel W.
    Chow, Lisa S.
    Smith, Glenn
    Barclay, Terry R.
    Dysken, Maurice
    Wyman, Jean F.
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 80 (01) : 233 - 244
  • [8] Effects of Exercise on Cognition: The Finnish Alzheimer Disease Exercise Trial: A Randomized, Controlled Trial
    Ohman, Hannareeta
    Savikko, Niina
    Strandberg, Timo E.
    Kautiainen, Hannu
    Raivio, Minna M.
    Laakkonen, Marja-Liisa
    Tilvis, Reijo
    Pitkala, Kaisu H.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 (04) : 731 - 738
  • [9] Effects of Yoga and Aerobic Exercise on Verbal Fluency in Physically Inactive Older Adults: Randomized Controlled Trial (FitForAge)
    Welford, Paul
    Osth, Josefine
    Hoy, Sara
    Rossell, Susan L.
    Pascoe, Michaela
    Diwan, Vinod
    Hallgren, Mats
    CLINICAL INTERVENTIONS IN AGING, 2023, 18 : 533 - 545
  • [10] Investigating Gains in Neurocognition in an Intervention Trial of Exercise (IGNITE): Protocol
    Erickson, Kirk I.
    Grove, George A.
    Burns, Jeffrey M.
    Hillman, Charles H.
    Kramer, Arthur F.
    McAuley, Edward
    Vidoni, Eric D.
    Becker, James T.
    Butters, Meryl A.
    Gray, Katerina
    Huang, Haiqing
    Jakicic, John M.
    Kamboh, M. Ilyas
    Kang, Chaeryon
    Klunk, William E.
    Lee, Phil
    Marsland, Anna L.
    Mettenburg, Joseph
    Rogers, Renee J.
    Stillman, Chelsea M.
    Sutton, Bradley P.
    Szabo-Reed, Amanda
    Verstynen, Timothy D.
    Watt, Jennifer C.
    Weinstein, Andrea M.
    Wollam, Mariegold E.
    CONTEMPORARY CLINICAL TRIALS, 2019, 85